<SEC-DOCUMENT>0001213900-26-000315.txt : 20260102
<SEC-HEADER>0001213900-26-000315.hdr.sgml : 20260102
<ACCEPTANCE-DATETIME>20260102131502
ACCESSION NUMBER:		0001213900-26-000315
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		20
FILED AS OF DATE:		20260102
DATE AS OF CHANGE:		20260102
EFFECTIVENESS DATE:		20260102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			YD Bio Ltd
		CENTRAL INDEX KEY:			0002011674
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-292554
		FILM NUMBER:		26501477

	BUSINESS ADDRESS:	
		STREET 1:		955 WEST JOHN CARPENTER FREEWAY
		STREET 2:		SUITE 100-929
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		619-500-7747

	MAIL ADDRESS:	
		STREET 1:		955 WEST JOHN CARPENTER FREEWAY
		STREET 2:		SUITE 100-929
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	True Velocity, Inc./DE
		DATE OF NAME CHANGE:	20240209
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ea0271168-s8_ydbio.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the United States Securities
and Exchange Commission on January 2, 2026.</B></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington<FONT STYLE="text-transform: uppercase">,
D.C. 20549</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase; text-underline-style: thick">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>FORM
s-8</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>REGISTRATION
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>UNDER
THE SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase; text-underline-style: thick">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>YD Bio Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-underline-style: thick"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-underline-style: thick"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap; width: 49%"><B>Cayman
    Islands</B></TD>
    <TD STYLE="text-align: center; width: 2%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.5pt solid; white-space: nowrap; width: 49%; font-size: 10pt; text-align: center"><B>Not
    Applicable</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: top; white-space: nowrap; font-size: 10pt; text-align: center">(State or Other Jurisdiction of Incorporation
    or Organization)</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; white-space: nowrap; font-size: 10pt; text-align: center">(I.R.S. Employer Identification Number)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: center"><B>12F.,
    No. 3, Xingnan St.,<BR> Nangang Dist.,<BR> Taipei City, Taiwan</B></TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: center"><B>115001</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: top; white-space: nowrap; font-size: 10pt; text-align: center">(Address of Principal Executive Offices)</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; white-space: nowrap; font-size: 10pt; text-align: center">(Zip Code)</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>YD Bio Limited Equity
Incentive Plan</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(Full Title of Plans)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Cogency Global Inc.<BR>
122 East 42<SUP>nd</SUP>&nbsp;Street,&nbsp;18<SUP>th</SUP>&nbsp;Floor<BR> New York,&nbsp;NY&nbsp;10168<BR> (212)&nbsp;947-7200</B></P>



<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(Name, address, and telephone
number, including area code, of agent for service) </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Copies to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Michael J. Blankenship
<BR>
Winston &amp; Strawn LLP<BR>
800 Capitol Street, Suite 2400 <BR>
Houston, Texas 77002<BR>
(713) 651-2600</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging
growth company. See the definitions of &ldquo;large accelerated filer&rdquo;, &ldquo;accelerated filer&rdquo;, &ldquo;smaller reporting
company&rdquo;, and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%">Large accelerated filer</TD>
    <TD STYLE="width: 25%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="width: 25%; font-size: 10pt">Accelerated filer</TD>
    <TD STYLE="width: 25%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Non-accelerated filer</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD>
    <TD STYLE="font-size: 10pt">Smaller reporting company</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Emerging growth company</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Part
I</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">INFORMATION
REQUIRED IN THE<BR>
SECTION 10(<FONT STYLE="text-transform: none">a</FONT>) PROSPECTUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The documents containing
information specified by Part I of Form S-8 will be sent or given to participants in the YD Bio Limited Equity Incentive Plan (the &ldquo;Plan&rdquo;),
as specified in Rule 428(b)(1) promulgated by the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) under the Securities
Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). Such documents are not being filed with the Commission but constitute (along
with the documents incorporated by reference into this Registration Statement on Form S-8 (this &ldquo;Registration Statement&rdquo;)
pursuant to Item 3 of Part II hereof), a prospectus that meets the requirements of Section 10(a) of the Securities Act.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">PART
II</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Item 3. Incorporation
of Documents by Reference</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents that
YD Bio Limited (the &ldquo;Company&rdquo; or &ldquo;we&rdquo;) has filed with the Commission under the Securities Act and the Securities
Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) are incorporated by reference into this Registration Statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">The Company&rsquo;s prospectus, dated
                                            <A HREF="https://www.sec.gov/Archives/edgar/data/2011674/000121390025111629/ea026548301-424b3_ydbio.htm">November
                                            17, 2025</A>, filed with the Commission on such date pursuant to Rule 424(b) under the Securities
                                            Act, related to the Company&rsquo;s registration statement on <A HREF="https://www.sec.gov/Archives/edgar/data/2011674/000121390025090653/ea0257287-f1_ydbio.htm">Form F-1</A> (Registration No. 333-290471);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">The description of the Company&rsquo;s
                                            ordinary shares contained in the &ldquo;Description of Registrant&rsquo;s Securities to be
                                            Registered&rdquo; in the Company&rsquo;s Form 8-A filed with the Commission on <A HREF="https://www.sec.gov/Archives/edgar/data/2011674/000121390025078815/ea0253957-8a12b_ydbio.htm">August
                                            20, 2025</A>, and any subsequent amendment or report filed for the purpose of updating such
                                            description.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All reports and other documents
subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective
amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities
then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part thereof from the
date of filing of such documents with the Commission. Any reports on Form 6-K furnished by the Company in the future will be deemed incorporated
by reference into this Registration Statement only to the extent that the Company expressly indicates that such reports are incorporated
herein. Any statement contained in a document incorporated, or deemed to be incorporated, by reference in this Registration Statement
shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in
this Registration Statement, or in any other subsequently filed document that also is or is deemed to be incorporated by reference in
this Registration Statement, modifies or supersedes such prior statement. Any statement contained in this Registration Statement shall
be deemed to be modified or superseded to the extent that a statement contained in a subsequently filed document that is, or is deemed
to be incorporated, by reference in this Registration Statement modifies or supersedes such prior statement. Any statement so modified
or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No document or information
deemed to be furnished and not filed in accordance with the rules of the Commission shall be deemed to be incorporated herein by reference
unless such document or information expressly provides to the contrary.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Item 4. Description of
Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Item 5. Interests of Named
Experts and Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Item 6. Indemnification
of Directors and Officers</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">YD Bio
Limited is Incorporated Under the Laws of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cayman Islands law does not
limit the extent to which a company&rsquo;s articles of association may provide for indemnification of officers and directors, except
to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification
against civil fraud or the consequences of committing a crime.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&rsquo;s Second
Amended and Restated Memorandum and Articles of Association, as adopted by special resolution of the Company passed on July 7, 2025 with
effect from August 26, 2025, provide that to the extent permitted by law, the Company shall indemnify each existing or former director
(including alternate director), secretary and other officer (including an investment adviser or an administrator or liquidator) and their
personal representatives against:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify">all actions, proceedings, costs, charges, expenses, losses,
damages, or liabilities incurred or sustained by the existing or former director (including alternate director), secretary, or officer
in or about the conduct of our business or affairs or in the execution or discharge of the existing or former director (including alternate
director)&rsquo;s, secretary&rsquo;s, or officer&rsquo;s duties, powers, authorities or discretions; and</TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify">without limitation to paragraph (a)&nbsp;above, all costs, expenses,
losses, or liabilities incurred by the existing or former director (including alternate director), secretary, or officer in defending
(whether successfully or otherwise) any civil, criminal, administrative or investigative proceedings (whether threatened, pending or
completed) concerning the Company or its affairs in any court or tribunal, whether in the Cayman Islands or elsewhere.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No such existing or former
director (including alternate director), secretary, or officer, however, shall be indemnified in respect of any matter arising out of
his own dishonesty, fraud, wilful default and wilful neglect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent permitted by
law, the Company may make a payment, or agree to make a payment, whether by way of advance, loan or otherwise, for any legal costs incurred
by an existing or former director (including alternate director), secretary or officer of the Company in respect of any matter identified
above on condition that the director (including alternate director), secretary or officer must repay the amount paid by the Company to
the extent that it is ultimately found not liable to indemnify the director (including alternate director), secretary or officer for
those legal costs.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Indemnification
Agreements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company entered into
indemnification agreements with its directors and executive officers, pursuant to which the Company agreed to indemnify each such person
against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being a director
or officer of the Company. The Company&rsquo;s obligations under the indemnification agreements are subject to certain customary restrictions
and exceptions. The form of such indemnification agreement was previously filed as Exhibit 4.14 to the Company&rsquo;s Form F-20F12B.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Directors&rsquo;
and Officers&rsquo; Liability Insurance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company maintains standard
policies of insurance under which coverage is provided to its directors and officers against the cost of defense, settlement or payment
of a judgment in some circumstances and insures the Company against its obligations to indemnify its officers and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Company pursuant
to the foregoing provisions, the Company has been informed that in the opinion of the Commission such indemnification is against public
policy as expressed in the Securities Act and is theretofore unenforceable.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Item 7. Exemption from
Registration Claimed</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Item 8. Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The exhibits filed herewith
or incorporated by reference herein are set forth in the Exhibit Index filed as part of this Registration Statement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">exhibit index</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><B>Exhibit No.</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; width: 90%"><B>Description</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>4.1</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/2011674/000121390025085063/ea025595901ex1-1_ydbio.htm">Second Amended and Restated Memorandum and Articles of Association of YD Bio Limited, as adopted by special resolution of the Company passed on July 7, 2025 with effect from August 26, 2025 (incorporated by reference to Exhibit 1.1 of the Company&rsquo;s Registration Statement on Form 20-F filed on September 5, 2025)</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>5.1*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027116801ex5-1_ydbio.htm">Opinion of Ogier</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>10.1*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027116801ex10-1_ydbio.htm">YD Bio Limited Equity Incentive Plan</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>23.1*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027116801ex5-1_ydbio.htm">Consent of Ogier &nbsp;(included in Exhibit 5.1)</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>23.2*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027116801ex23-2_ydbio.htm">Consent of &nbsp;CBIZ CPAs P.C.</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>23.3*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027116801ex23-3_ydbio.htm">Consent of &nbsp;Marcum LLP</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>23.4*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027116801ex23-4_ydbio.htm">Consent of &nbsp;ARK Pro CPA &amp; Co</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>24.1*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#poa_001">Power of Attorney (set forth on signature page)&nbsp;</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>107*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027116801ex-fee_ydbio.htm">Filing Fee Table</A></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>*</B></TD><TD STYLE="text-align: justify"><B>Filed herewith.</B></TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Item 9. Undertakings</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a) The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">(1) To file, during
any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(i) To include any prospectus required
by Section 10(a)(3) of the Securities Act</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(ii) To reflect in the prospectus any
facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than a 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration
Fee&rdquo; table in the effective registration statement and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(iii) To include any material information
with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information
in this Registration Statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>provided</I>, <I>however</I>, that paragraphs
(a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is
contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange
Act that are incorporated by reference in this Registration Statement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">(2) That, for the
purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">(3) To remove from
registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of
the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The undersigned registrant hereby undertakes
that, for purposes of determining any liability under the Securities Act, each filing of the registrant's annual report pursuant to Section
13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to
Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing
provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the
registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="poa_001"></A>SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form S-8 and has duly caused this Registration Statement on Form S-8 to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Taipei, Taiwan on the 2nd day of January, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>YD Bio Limited</B></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><I>/s/ Ethan Shen</I></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name:&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Ethan Shen</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Title:</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Chief Executive Officer and Chairman</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><I>/s/ Edmund Hen</I></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt">Edmund Hen</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Title:</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Chief Financial Officer</TD>
    </TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">powers of attorney</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned officers
and directors do hereby constitute and appoint Ethan Shen and Edmund Hen, and any of them, with full power of substitution and re-substitution,
as our true and lawful attorneys-in-fact and agents, to do any and all acts and things in our name and behalf in our capacities as directors
and officers, and to execute any and all instruments for us and in our names in the capacities indicated below, that such persons may
deem necessary or advisable to enable the Company to comply with the Securities Act and any rules, regulations and requirements of the
Commission in connection with this Registration Statement, including specifically, but not limited to, power and authority to sign for
us, any of us, in the capacities indicated below, any and all amendments hereto (including post-effective amendments)&#894; and we do
hereby ratify and confirm all that said attorneys-in-fact and agents or any of them or their or his substitutes or substitute, may lawfully
do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 32%; font-size: 10pt; text-align: center"><B>Signature</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 46%; font-size: 10pt; text-align: center"><B>Title</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 21%; font-size: 10pt; text-align: center"><B>Date</B></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Ethan Shen</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center; vertical-align: bottom">Chief Executive Officer and Chairman<BR> (Principal Executive
    Officer)</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">January 2, 2026</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">Ethan Shen</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Edmund Hen</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center; vertical-align: bottom">Chief Financial Officer<BR> (Principal Financial and Accounting
    Officer)</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">January 2, 2026</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">Edmund Hen</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Benjamin Zhang</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">Chief Medical Officer and Director</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">January 2, 2026</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">Benjamin Zhang</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Michaela Griggs</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">Director</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">January 2, 2026</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">Michaela Griggs</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Jan Hall</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">Director</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">January 2, 2026</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">Jan Hall</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Jerry Lee</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">Director</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">January 2, 2026</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">Jerry Lee</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Albert McLelland</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">Director</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">January 2, 2026</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">Albert McLelland</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    J. Douglas Ramsey</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">Director</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">January 2, 2026</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">J. Douglas Ramsey</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AUTHORIZED REPRESENTATIVE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act, the undersigned has signed this Registration Statement, in the capacity of the duly authorized representative of the Company in
the United States, on January 2, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
    U.S. Representative</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cogency Global Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By: </FONT><I>&nbsp;</I></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Colleen A. De Vries</I></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen A. De Vries</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title: &nbsp;</FONT>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Vice President
    </FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">II-6</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea027116801ex5-1_ydbio.htm
<DESCRIPTION>OPINION OF OGIER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 228.15pt"><B>Exhibit 5.1</B></P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 67%"><FONT STYLE="font-size: 10pt"><B>YD Bio Limited </B></FONT></TD>
    <TD STYLE="text-align: right; width: 6%"><FONT STYLE="font-size: 10pt">D:&nbsp;</FONT></TD>
    <TD STYLE="width: 27%"><FONT STYLE="font-size: 10pt">+852 3656 6054 /</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">c/o - Ogier Global (Cayman) Limited </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">+852 3656 6061</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">89 Nexus Way, Camana Bay </font></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Grand Cayman, KY1-9009 </font></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">E:&nbsp;</FONT></TD>
    <TD> <FONT STYLE="font-size: 10pt">nathan.powell@ogier.com /</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Cayman Islands</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">florence.chan@ogier.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>Reference:&nbsp;</TD>
    <TD>FYC/AGC/515297.00001</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>2 January 2026</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Dear Sirs</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify"><B>YD Bio Limited (the Company)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">We have acted as Cayman Islands counsel
to the Company in connection with the Company&rsquo;s registration statement on Form S-8, including all amendments and supplements thereto
(the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Form S- 8</B></FONT>), as filed with the United States Securities and
Exchange Commission (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Commission</B></FONT>) under the United States Securities
Act of 1933, as amended (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Act</B></FONT>) on or about the date hereof.
The Form S-8 relates to the registration under the Act of the ordinary shares of par value of US$0.0001 each to be issued by the Company
pursuant to the Equity Incentive Plan of the Company as approved by the board of directors of the Company and the then sole shareholder
of the Company both on 7 July 2025 (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Equity Incentive Plan</B></FONT>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Unless a contrary intention appears,
all capitalised terms used in this opinion have the respective meanings set forth in the Documents (as defined below). A reference to
a Schedule is a reference to a schedule to this opinion and the headings herein are for convenience only and do not affect the construction
of this opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">1</TD><TD>Documents examined</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">For the purposes of giving this opinion, we have examined
originals, copies, or drafts of the following documents (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Documents</B></FONT>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the certificate of registration by way of continuation of the Company (previously known as TRUE VELOCITY,
INC.) dated 14 November 2024 issued by the Registrar of Companies of the Cayman Islands (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Registrar</B></FONT>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the certificate of incorporation on change of name of the Company dated 18 November 2024 issued by the
Registrar;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the second amended and restated memorandum and articles of association of the Company adopted by special resolution of the Company passed
on 7 July 2025 with effect from 26 August 2025 (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Memorandum </B></FONT>and
<FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Articles</B></FONT>);</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Ogier</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Providing
    advice on British Virgin Islands,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cayman Islands and Guernsey laws</FONT></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 36%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 17%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 17%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Floor
    11 Central Tower</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">28
    Queen&rsquo;s Road Central</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Central</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Hong
    Kong</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">T
    +852 3656 6000</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">F
    +852 3656 6001</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>ogier.com</B></FONT></P></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Partners</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nicholas
    Plowman</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nathan
    Powell</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Anthony
    Oakes</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Oliver
    Payne</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Kate
    Hodson</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">David
    Nelson</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Justin
    Davis</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Joanne
    Collett</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Dennis
    Li</FONT></P></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cecilia
    Li</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Yuki
    Yan</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">David
    Lin</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Alan
    Wong</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Rachel
    Huang**</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Janice
    Chu**</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Florence
    Chan*<SUP>&Dagger;</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Richard
    Bennett**<SUP>&Dagger;</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">James
    Bergstrom<SUP>&Dagger;</SUP></FONT></P></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">*&nbsp;&nbsp;&nbsp;admitted
    in New Zealand</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">**&nbsp;admitted
    in England and Wales</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><SUP>&Dagger;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</SUP>not ordinarily resident in Hong Kong</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.55pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Page <B>2</B> of <B>4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">a certificate of good standing dated 29 December 2025 issued by the Registrar in respect of the Company
(the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Good Standing Certificate</B></FONT>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD>the register of directors and officers of the Company dated 25 November
                                            2025 (the <B>ROD</B>);</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">the shareholder list of the Company as at 8 December 2025 provided to us on 9 December 2025 (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ROM</B></FONT>,
and together with the ROD, the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Registers</B></FONT>);</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">the written resolution of all the directors of the Company dated 7 July 2025 approving, among other things,
the Company&rsquo;s adoption of Equity Incentive Plan (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Board Resolution</B></FONT>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">the written resolution of the sole shareholder of the Company dated 7 July 2025 approving, among other
things, the Company&rsquo;s adoption of the Equity Incentive Plan (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Shareholder
Resolution</B></FONT>, together with the Board Resolution, the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Reviewed Resolutions</B></FONT>);</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">a certificate from a director of the Company dated 2 January 2026 as to certain matters of fact (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Director&rsquo;s Certificate</B></FONT>);</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD>the Form S-8; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD>the Equity Incentive Plan as exhibited to the Form S-8.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>2</B></TD><TD><B>Assumptions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In giving this opinion we have relied
upon the assumptions set forth in this paragraph 2 without having carried out any independent investigation or verification in respect
of those assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>all original documents examined by us are authentic and complete;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">all copy documents examined by us (whether in facsimile, electronic or other form) conform to the originals
and those originals are authentic and complete;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">all signatures, seals, dates, stamps and markings (whether on original or copy documents) are genuine;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">each of the Registers, the Director&rsquo;s Certificate and the Equity Incentive Plan is accurate, complete
and up-to-date (as the case may be) as at the date of this opinion;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">the Memorandum and Articles provided to us are in full force and effect and have not been amended, varied,
supplemented or revoked in any respect;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">all copies of the Form S-8 are true and correct copies and the Form S-8 conforms in every material respect
to the latest drafts of the same produced to us and, where the Form S-8 has been provided to us in successive drafts marked to show changes
from a previous draft, all such changes have been accurately marked;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">the Reviewed Resolutions have been duly passed in accordance with the Company&rsquo;s articles of association
then in effect and remains in full force and effect;</TD></TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page <B>3</B> of <B>4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">each of the directors of the Company has acted in good faith with a view to the best interests of the
Company and has exercised the standard of care, diligence and skill that is required of him or her in approving the Equity Incentive Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">neither the directors and shareholders of the Company have taken any steps to wind up the Company or to
appoint a liquidator of the Company and no receiver or restructuring officer has been appointed over any of the Company&rsquo;s property
or assets;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">the maximum number of shares which the Company is required to issue under the Equity Incentive Plan to
fulfil its obligation (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ESOP Shares</B></FONT>) will not exceed the Company&rsquo;s
authorised share capital then in place;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">the consideration payable for each ESOP Share shall be no less than the par value of the ESOP Shares;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">there is nothing under any law (other than the laws of the Cayman Islands), that would or might affect
the opinions herein.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>3</B></TD><TD><B>Opinions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On the basis of the examination of
the Documents and assumptions referred to above and subject to the limitations and qualifications set forth in paragraph 4 below, we are
of the opinion that:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Authorised
Shares</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Based solely on the Memorandum, the authorised share capital of the Company is US$50,000 divided into
500,000,000 ordinary shares of par value US$0.0001 each.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Valid Issuance
of ESOP Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The ESOP Shares to be issued under the Equity Incentive Plan have been duly authorised by all necessary
corporate actions of the Company under the Memorandum and Articles and, upon the issuance and delivery of the ESOP Shares in accordance
with the Memorandum and Articles, the Reviewed Resolutions and the terms of the Equity Incentive Plan and once consideration of not less
than the par value per ESOP Share is fully paid in accordance with the Equity Incentive Plan to the Company, the ESOP Shares will be validly
issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Once the register of members of the Company has been updated to reflect the issuance of the ESOP Shares,
the shareholders recorded in the register of members of the Company will be deemed to have legal title to the shares of the Company set
out against their respective name.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>4</B></TD><TD><B>Limitations and Qualifications</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">4.1</TD><TD>We offer no opinion:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">as to any laws other than the laws of the Cayman Islands, and we have not, for the purposes of this opinion,
made any investigation of the laws of any other jurisdiction, and we express no opinion as to the meaning, validity, or effect of references
in the Equity Incentive Plan to statutes, rules, regulations, codes
or judicial authority of any jurisdiction other than the Cayman Islands; or</TD></TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page <B>4</B> of <B>4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">except to the extent that this opinion expressly provides otherwise, as to the commercial terms of, or
the validity, enforceability or effect of the Form S-8, the accuracy of representations, the fulfilment of warranties or conditions, the
occurrence of events of default or terminating events or the existence of any conflicts or inconsistencies among the Form S-8 and any
other agreements into which the Company may have entered or any other documents.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">Under the Companies Act (Revised) (<FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Companies
Act</B></FONT>) of the Cayman Islands annual returns in respect of the Company must be filed with the Registrar of Companies in the Cayman
Islands, together with payment of annual filing fees. A failure to file annual returns and pay annual filing fees may result in the Company
being struck off the Register of Companies, following which its assets will vest in the Financial Secretary of the Cayman Islands and
will be subject to disposition or retention for the benefit of the public of the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>5</B></TD><TD><B>Governing law of this opinion</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">5.1</TD><TD>This opinion is:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">governed by, and shall be construed in accordance with, the laws of the Cayman Islands;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>limited to the matters expressly stated in it; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.1pt; text-align: justify; text-indent: -35.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">confined to, and given on the basis of, the laws and practice in the Cayman Islands at the date of this
opinion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">5.2</TD><TD STYLE="text-align: justify">Unless otherwise indicated, a reference to any specific Cayman Islands legislation is a reference to that
legislation as amended to, and as in force at, the date of this opinion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">6</TD><TD>Reliance</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">We hereby consent to the filing of this opinion as an exhibit
to the Form S-8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">This opinion may be used only in connection with the Form
S-8 while the Equity Incentive Plan is effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Yours faithfully</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: left">/s/ <B>Ogier</B></TD><TD STYLE="text-align: justify; width: 60%"><B>&nbsp;</B></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 40%; text-align: left"><B>Ogier</B></TD><TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ea027116801ex10-1_ydbio.htm
<DESCRIPTION>YD BIO LIMITED EQUITY INCENTIVE PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>YD BIO LIMITED<BR>
EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 1. <I>Purpose.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The purpose of the YD Bio Limited
Equity Incentive Plan (as amended from time to time, &ldquo;<B>Equity Plan</B>&rdquo;) is to enhance the ability of YD Bio Limited (the
&ldquo;<B>Company</B>&rdquo;) to attract and retain exceptionally qualified individuals and to encourage them to acquire a proprietary
interest in the growth and performance of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This Equity Plan is adopted
by the Company in connection with the anticipated consummation of the Business Combination. From and after the time of the Business Combination,
the Company intends to use this Equity Plan to grant new Awards to eligible Participants from time to time, subject to and in accordance
with the terms and conditions described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 2<I>. Structure</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each Award (as defined below)
granted by the Company pursuant to the terms of this Equity Plan, shall be granted to each participant, and the corresponding Shares issuable
upon the exercise of such Award (the &ldquo;<B>Award Shares</B>&rdquo;) shall be issued to the participants or an entity designated by
the participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 3<I>. Definitions.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As used in this Equity Plan
and any Award Agreement (as defined below), the following terms shall have the meanings set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) &ldquo;<B>Equity Plan</B>&rdquo;
shall have the meaning set forth in Section 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) &ldquo;<B>Administrator</B>&rdquo;
shall have the meaning set forth in Section 5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) &ldquo;<B>Affiliate</B>&rdquo;
shall mean (i) any entity that, directly or indirectly, is controlled by the Company and (ii) any entity in which the Company has a significant
equity interest, in either case as determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d) &ldquo;<B>Applicable Laws</B>&rdquo;
shall mean all laws, statutes, regulations, ordinances, rules or governmental requirements that are applicable to this Equity Plan or
any Award granted pursuant to this Equity Plan, including but not limited to applicable laws of the Singapore, the United States and the
Cayman Islands, and the rules and requirements of any applicable securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e) &ldquo;<B>Award</B>&rdquo;
shall mean any Option, award of Restricted Share, Restricted Share Unit or Other Share-Based Award granted under this Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(f) &ldquo;<B>Award Agreement</B>&rdquo;
shall mean any written agreement, contract or other instrument or document evidencing any Award granted under this Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(g) &ldquo;<B>Board</B>&rdquo;
shall mean the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(h) &ldquo;<B>Business Combination</B>&rdquo;
shall mean the transactions contemplated by that certain Agreement and Plan of Merger (&ldquo;<B>Merger Agreement</B>&rdquo;) dated September
24, 2024 (as may be amended, supplemented or otherwise modified from time to time, the &ldquo;<B><I>Merger Agreement</I></B>&rdquo;) by
and among (i) Breeze Holdings Acquisition Corp., (ii) the Company, (iii) Breeze Merger Sub, Inc., a Delaware corporation and which will
be a direct, wholly-owned subsidiary of the Company (&ldquo;Breeze Merger Sub&rdquo;), (iv) BH Biopharma Merger Sub Limited, a Cayman
Islands exempted company (&ldquo;Company Merger Sub,&rdquo; with Company Merger Sub and Breeze Merger Sub together referred to herein
as the &ldquo;Merger Subs&rdquo;), and (v) YD Biopharma Limited, a Cayman Islands exempted company (&ldquo;YD Biopharma&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(i) &ldquo;<B>Committee</B>&rdquo;
shall mean a compensation committee of the Board or another board committee designated by the Board to administer this Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(j) &ldquo;<B>Company</B>&rdquo;
shall mean YD Bio Limited, a company incorporated under the laws of the Cayman Islands, together with any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(k) &ldquo;<B>Consultant</B>&rdquo;
means any individual, including an advisor, who is engaged by the Company or an Affiliate to render services and is compensated for such
services, and any director of the Company whether or not compensated for such services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(l) [Reserved]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(m) &ldquo;<B>Fair Market Value</B>&rdquo;
shall mean, with respect to any property (including, without limitation, any Shares or other securities) the fair market value of such
property determined by such methods or procedures as shall be established from time to time by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(n) &ldquo;<B>Option</B>&rdquo;
shall mean an option granted under Section 7 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(o) &ldquo;<B>Other Share-Based
Award</B>&rdquo; shall mean a right granted under Section 9 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(p) &ldquo;<B>Participant</B>&rdquo;
shall mean an individual granted an Award under this Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(q) [Reserved]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(r) &ldquo;<B>Restricted Share</B>&rdquo;
shall mean any Share granted under Section 8 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(s) &ldquo;<B>Restricted Share
Unit</B>&rdquo; shall mean a contractual right granted under Section 8 hereof that is denominated in Shares, each of which represents
a right to receive the value of a Share (or a percentage of such value, which percentage may be higher than 100%) upon the terms and conditions
set forth in this Equity Plan and the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(t) &ldquo;<B>Shares</B>&rdquo;
shall mean Ordinary Shares of the Company, par value US$0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(u) &ldquo;<B>Substitute Awards</B>&rdquo;
shall mean Awards granted in assumption of, or in substitution for, outstanding awards previously granted by, or held by the employees
of, a company or other entity or business acquired (directly or indirectly) by the Company or with which the Company combines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 4<I>. Eligibility.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) Employees (each, an &ldquo;<B>Employee</B>&rdquo;)
and Consultants of the Company or an Affiliate are eligible to participate in this Equity Plan. An Employee or Consultant who has been
granted an Award may, if he or she is otherwise eligible, be granted additional Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) An individual who has agreed
to accept employment by, or to provide services to, the Company or an Affiliate shall be deemed to be eligible for Awards hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 5<I>. Administration.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) This Equity Plan shall
be administered by the Administrator formed in accordance with applicable laws and stock exchange rules, unless otherwise determined by
the Board. The term &ldquo;Administrator&rdquo; shall refer to the Board or the Committee, as applicable. The Administrator may delegate
its duties and powers under this Equity Plan in whole or in part to a person or a board committee designated by it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) Subject to the terms of
this Equity Plan and Applicable Laws, the Administrator shall have full power and authority to: (i) designate Participants; (ii) determine
the type or types of Awards (including Substitute Awards) to be granted to each Participant under this Equity Plan; (iii) determine the
number of Shares to be covered by (or with respect to which payments, rights, or other matters are to be calculated in connection with)
Awards; (iv) determine the terms and conditions of any Award including, but not limited to, any restrictions or limitations on the Award,
any schedule for lapse of forfeiture restrictions or restrictions on the exercisability of an Award, and accelerations or waivers thereof,
any provisions related to non-competition and recapture of gain on an Award, based in each case on such considerations as the Administrator
in its sole discretion determines; (v) determine whether, to what extent, and under what circumstances Awards may be settled or exercised
in cash, Shares, other securities, other Awards, or other property, or canceled, forfeited or suspended, and the method or methods by
which Awards may be settled, exercised, canceled, forfeited or suspended; (vi) determine whether, to what extent, and under what circumstances
cash, Shares, other securities, other Awards, other property, and other amounts payable with respect to an Award under this Equity Plan
shall be deferred either automatically or at the election of the holder thereof or of the Administrator; (vii) interpret and administer
this Equity Plan and any instrument or agreement relating to, or Award made under, this Equity Plan; (viii) establish, amend, suspend
or waive such rules and regulations and appoint such agents as it shall deem appropriate for the proper administration of this Equity
Plan; (ix) determine whether and to what extent Awards should comply or continue to comply with any requirement of statute or regulation;
(x) determine whether and to what extent Awards should continue being effective in the event of a change of control of the Company including,
but not limited to, canceling Awards and causing to be paid to the holders of vested Awards the value of such Awards, if any, as determined
by the Administrator, in its sole discretion, it being understood that in the case of any Option with an exercise price that equals or
exceeds the price paid for a Share in connection with a change of control of the Company, the Administrator may cancel the Option without
the payment of consideration therefor; and (xi) make any other determination and take any other action that the Administrator deems necessary
or desirable for the administration of this Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) All decisions of the Administrator
shall be final, conclusive and binding upon all persons, including the Company, the shareholders of the Company and the Participants and
their beneficiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d) The Administrator may impose
restrictions on any Award with respect to non-competition, confidentiality, lock-up and any other events that it considers to be detrimental
to the Company, and impose other restrictive covenants as it deems necessary or appropriate in its ssharesole discretion. In the event
that these restrictions are breached, the Administrator may request the Participants to return all benefits made available to them under
this Equity Plan and such Participants shall cease to be entitled to potential benefits intended to be made available to them under this
Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 6<I>. Shares Available for Awards.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 10pt">(a)
Subject to adjustment as provided below, the maximum aggregate number of Shares that may be issued pursuant to all Awards shall initially
not exceed 10,547,974 Shares. In addition, subject to any adjustments as necessary provided in this Equity Plan, such aggregate number
of shares of Shares will automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2026 and
ending on (and including) January 1, 2035, in an amount equal to 3% of the total number of shares of Shares outstanding on December 31
of the preceding year; provided, however, that the Board may act prior to January 1</FONT><SUP>st</SUP> <FONT STYLE="font-size: 10pt">of
a given year to provide that the increase for such year will be a lesser number of shares of Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) If, after the effective
date of this Equity Plan, any Shares covered by an Award, or to which such an Award relates, are forfeited, cancelled or if such an Award
otherwise terminates without the delivery of Shares or of other consideration, then the Shares covered by such Award, or to which such
Award relates, to the extent of any such forfeiture or termination, shall again be, or shall become, available for issuance under this
Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) In the event that any Option
or other Award granted hereunder (other than a Substitute Award) is exercised through the delivery of Shares, or in the event that withholding
tax liabilities arising from such Option or Award are satisfied by the withholding of Shares by the Company, the number of Shares available
for Awards under this Equity Plan shall be increased by the number of Shares so surrendered or withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d) Any Shares delivered pursuant
to an Award may consist, in whole or in part, of authorized and unissued Shares, treasury Shares or Shares purchased on the open market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e) In the event that the Administrator
shall determine that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization,
stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Shares
or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities of the Company, or other
similar corporate transaction or event affects the Shares such that an adjustment is determined, in its absolute discretion, by the Administrator
to be appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under
this Equity Plan, then the Administrator shall, in such manner as it may deem appropriate, adjust any or all of (i) the number and type
of Shares (or other securities or property) which thereafter may be made the subject of Awards, including the aggregate limit specified
in Section 6(a) hereof, (ii) the number and type of Shares (or other securities or property) subject to outstanding Awards, (iii) the
grant price, purchase price, or exercise price with respect to any Award or, if deemed appropriate, make provision for a cash payment
to the holder of an outstanding Award, and (iv) the minimum number of Shares which may be acquired by the holder of an outstanding Award
at any one time; <I>provided, however</I>, that the number of Shares subject to any Award denominated in Shares shall always be a whole
number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(f) Shares underlying Substitute
Awards shall not reduce the number of Shares remaining available for issuance under this Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(g) Except as expressly provided
in this Equity Plan, no Participant shall have any rights by reason of any subdivision or consolidation of Shares of any class, the payment
of any dividend, any increase or decrease in the number of shares of any class or any dissolution, liquidation, merger, or consolidation
of the Company or any other corporation. Except as expressly provided in this Equity Plan or pursuant to action of the Administrator under
this Equity Plan, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect,
and no adjustment by reason thereof shall be made with respect to, the number of shares subject to an Award or the grant or exercise price
of any Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 7. <I>Options</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Administrator is hereby
authorized to grant Options to Participants with the following terms and conditions and with such additional terms and conditions, in
either case not inconsistent with the provisions of this Equity Plan, as the Administrator shall determine and set forth in the Award
Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) The purchase price per
Share under an Option shall be determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) The term of each Option
shall be fixed by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) The Administrator shall
determine the time or times at which an Option may be exercised in whole or in part, and the method or methods by which, and the form
or forms, including, without limitation, cash, Shares, other Awards, or other property, or any combination thereof, having a Fair Market
Value on the exercise date equal to the relevant exercise price, in which, payment of the exercise price with respect thereto may be made
or deemed to have been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 8<I>. Restricted Shares and Restricted
Share Units.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) The Administrator is hereby
authorized to grant Awards of Restricted Shares and Restricted Share Units to Participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) Restricted Shares and Restricted
Share Units shall be subject to such restrictions as the Administrator may impose (including, without limitation, any limitation on the
right to vote a Restricted Share or the right to receive any dividend or other right or property), which restrictions may lapse separately
or in combination at such time or times, in such installments or otherwise, as the Administrator may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) Any Restricted Share granted
under this Equity Plan may be evidenced in such manner as the Administrator may deem appropriate including, without limitation, book-entry
registration or issuance of a share certificate or certificates, creation of a new class of shares or amendment of the Memorandum and/or
Articles of Association of the Company. In the event any share certificate is issued in respect of Restricted Shares granted under this
Equity Plan, such certificate shall be registered in the name of the Participant and shall bear an appropriate legend referring to the
terms, conditions, and restrictions applicable to such Restricted Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 9<I>. Other Share-Based Awards.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Administrator is hereby
authorized to grant to Participants such other Awards (including, without limitation, share appreciation rights and rights to dividends
and dividend equivalents) that are denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related
to, Shares (including, without limitation, securities convertible into Shares) as are deemed by the Administrator to be consistent with
the purposes of this Equity Plan. Subject to the terms of this Equity Plan, the Administrator shall determine the terms and conditions
of such Awards. Shares or other securities delivered pursuant to a purchase right granted under this Section 9 shall be purchased for
such consideration, which may be paid by such method or methods and in such form or forms, including, without limitation, cash, Shares,
other securities, other Awards, or other property, or any combination thereof, as the Administrator shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 10<I>. General Provisions Applicable to
Awards.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) All Awards shall be evidenced
by an Award Agreement between the Company and each Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) Awards shall be granted
for no cash consideration or for such minimal cash consideration as may be required by Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) Awards may, in the discretion
of the Administrator, be granted either alone or in addition to or in tandem with any other Award or any award granted under any other
plan of the Company. Awards granted in addition to or in tandem with other Awards, or in addition to or in tandem with awards granted
under any other plan of the Company, may be granted either at the same time as or at a different time from the grant of such other Awards
or awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d) Subject to the terms of
this Equity Plan, payments or transfers to be made by the Company upon the grant, exercise or payment of an Award may be made in such
form or forms as the Administrator shall determine including, without limitation, cash, Shares, other securities, other Awards, or other
property, or any combination thereof, and may be made in a single payment or transfer, in installments, or on a deferred basis, in each
case in accordance with rules and procedures established by the Administrator. Such rules and procedures may include, without limitation,
provisions for the payment or crediting of reasonable interest on installment or deferred payments or the grant or crediting of dividend
equivalents in respect of installment or deferred payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e) Unless the Board or the
Administrator shall otherwise determine, no Award and no right under any such Award, shall be assignable, alienable, saleable or transferable
by a Participant otherwise than by will or by the laws of descent and distribution; provided, however, that, if so determined by the Administrator
or the Board, a Participant may, in the manner established by the Administrator, designate a beneficiary or beneficiaries to exercise
the rights of the Participant, and to receive any property distributable, with respect to any Award upon the death of the Participant.
Each Award, and each right under any Award, shall be exercisable during the Participant&rsquo;s lifetime only by the Participant or, if
permissible under Applicable Laws and the applicable Award Agreement, by the Participant&rsquo;s guardian or legal representative. No
Award and no right under any such Award, may be pledged, charged, mortgaged, alienated, attached, or otherwise encumbered, and any purported
pledge, charge, mortgage, alienation, attachment or encumbrance thereof shall be void and unenforceable against the Company. The provisions
of this paragraph shall not apply to any Award which has been fully exercised, earned or paid, as the case may be, and shall not preclude
forfeiture of an Award in accordance with the terms hereof and of the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(f) All certificates for Shares
or other securities delivered under this Equity Plan pursuant to any Award or the exercise thereof shall be subject to such stop transfer
orders and other restrictions as the Administrator may deem advisable under this Equity Plan or the rules, regulations, and other requirements
of the United States Securities and Exchange Commission, any stock exchange upon which such Shares or other securities are then listed,
and any Applicable Laws, and the Administrator may cause a legend or legends to be put on any such certificates to make appropriate reference
to such restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(g) No Shares shall be delivered
under the Equity Plan to any Participant until such Participant has made arrangements acceptable to the Administrator for the satisfaction
of any income and employment tax withholding obligations under Applicable Laws. The Company or any of its subsidiaries shall have the
authority and the right to deduct or withhold, or require a Participant to remit to the Company or its subsidiaries, an amount sufficient
to satisfy all applicable taxes (including the Participant&rsquo;s payroll tax obligations) required or permitted by Applicable Laws to
be withheld with respect to any taxable event concerning a Participant arising as a result of the Equity Plan. The Administrator may in
its discretion and in satisfaction of the foregoing requirement allow a Participant to elect to have the Company withhold Shares otherwise
issuable under an Award (or allow the return of Shares) having a Fair Market Value equal to the sum required to be withheld. Notwithstanding
any other provision of the Equity Plan, the number of Shares which may be withheld with respect to the issuance, vesting, exercise or
payment of any Award (or which may be repurchased from the Participant of such Award after such Shares were acquired by the Participant
from the Company) in order to satisfy any income and payroll tax liabilities applicable to the Participant with respect to the issuance,
vesting, exercise or payment of the Award shall, unless specifically approved by the Administrator, be limited to the number of Shares
which have a Fair Market Value on the date of withholding or repurchase equal to the aggregate amount of such liabilities based on the
minimum statutory withholding rates for the applicable income and payroll tax purposes that are applicable to such supplemental taxable
income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 11<I>. Amendment and Termination.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) Except to the extent prohibited
by Applicable Laws and unless otherwise expressly provided in an Award Agreement or in this Equity Plan, the Administrator may amend,
alter, suspend, discontinue or terminate this Equity Plan, or any Award Agreement hereunder or any portion hereof or thereof at any time;
<I>provided, however</I>, that no such amendment, alteration, suspension, discontinuation or termination shall be made without (i) shareholder
approval with such legally mandated threshold for a resolution of the shareholders of the Company, if such approval is necessary to comply
with any tax or regulatory requirement for which or with which the Administrator deems it necessary or desirable to qualify or comply,
(ii) shareholder approval with such threshold for a resolution of the shareholders of the Company in respect of such amendment, alteration,
suspension, discontinuation or termination as provided in the Company&rsquo;s Memorandum and Articles of Association for any amendment
to this Equity Plan that increases the total number of Shares reserved for the purposes of this Equity Plan, and (iii) with respect to
any Award Agreement, the consent of the affected Participant, if such action would materially and adversely affect the rights of such
Participant under any outstanding Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) The Administrator may waive
any conditions or rights under, amend any terms of, or amend, alter, suspend, discontinue or terminate, any Award theretofore granted,
prospectively or retroactively, without the consent of any relevant Participant or holder or beneficiary of an Award; <I>provided, however</I>,
that no such action shall materially and adversely affect the rights of any affected Participant or holder or beneficiary under any Award
theretofore granted under this Equity Plan; and <I>provided further</I> that, except as provided in Section 6(e) hereof, no such action
shall reduce the exercise price of any Option established at the time of grant thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) The Administrator shall
be authorized to make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring
events (including, without limitation, the events described in Section 6(e) hereof affecting the Company, or the financial statements
of the Company, or of changes in Applicable Laws or accounting principles); whenever the Administrator determines that such adjustments
are appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under
this Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d) Any provision of this Equity
Plan or any Award Agreement to the contrary notwithstanding, with the affected Participant&rsquo;s consent, the Administrator may cause
any Award granted hereunder to be canceled in consideration of a cash payment or alternative Award made to the holder of such canceled
Award equal in value to the Fair Market Value of such canceled Award as of the time of the cancellation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e) The Administrator may correct
any defect, supply any omission, or reconcile any inconsistency in this Equity Plan or any Award in the manner and to the extent it shall
deem desirable to carry this Equity Plan into effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 12<I>. Withholding Taxes</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The exercise of each Award
granted under this Equity Plan shall be subject to the condition that, if at any time, the Administrator shall determine that the satisfaction
of withholding tax is necessary or desirable in respect of such exercise, such exercise shall not be effective unless such withholding
has been effected to the satisfaction of the Administrator. In such circumstances, the Administrator may require the exercising Participant
to pay to the Company, in addition to and in the same manner as the exercise price for the Award Shares, such amount as the Company or
any Affiliate is obliged to remit to the relevant taxing authority in respect of the exercise of the Awards. Alternatively, the Administrator
may direct the Company or an Affiliate thereof to withhold the appropriate amount of tax from the applicable Participant&rsquo;s salary
in connection with a requested exercise. Any such additional payment shall be due no later than the date as of which any amount with respect
to the Award exercised first becomes includable in the gross income of the exercising Participant for tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 13<I>. Miscellaneous.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) No employee, independent
contractor, Participant or other person shall have any claim to be granted any Award under this Equity Plan, and there is no obligation
for uniformity of treatment of employees, independent contractors, Participants, or holders or beneficiaries of Awards under this Equity
Plan. The terms and conditions of Awards need not be the same with respect to each recipient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) Nothing contained in this
Equity Plan shall prevent the Company from adopting or continuing in effect other or additional compensation arrangements, and such arrangements
may be either generally applicable or applicable only in specific cases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) The grant of an Award shall
not be construed as giving a Participant the right to be retained in the employ or service of the Company or any Affiliate. Further, the
Company or the applicable Affiliate may at any time dismiss a Participant from employment or terminate the services of an independent
contractor, free from any liability, or any claim under this Equity Plan, unless otherwise expressly provided in this Equity Plan or in
any Award Agreement or in any other agreement binding upon the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d) If any provision of this
Equity Plan or any Award is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction, or as to any person
or Award, or would disqualify this Equity Plan or any Award under any Applicable Laws, such provision shall (to the fullest extent permitted
by Applicable Laws) be construed or deemed amended to conform to Applicable Laws, or if it cannot be so construed or deemed amended without,
in the determination of the Administrator, materially altering the intent of this Equity Plan or the Award, such provision shall be stricken
as to such jurisdiction, person or Award, and the remainder of this Equity Plan and any such Award shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e) Awards payable under this
Equity Plan shall be payable in Shares or from the general assets of the Company, and no special or separate reserve, fund or deposit
shall be made to assure payment of such awards. No Participant, beneficiary or other person shall have any right, title or interest in
any fund or in any specific asset (including Shares, except as expressly otherwise provided) of the Company or one of its subsidiaries
by reason of any award hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(f) Neither this Equity Plan
nor any Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company
and a Participant. To the extent that any person acquires a right to receive payments from the Company pursuant to an Award, such right
shall be no greater than the right of any unsecured general creditor of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(g) No fractional Shares shall
be issued or delivered pursuant to this Equity Plan or any Award, and the Administrator shall determine whether cash, other securities
or other property shall be paid or transferred in lieu of any fractional Shares, or whether such fractional Shares or any rights thereto
shall be canceled, terminated or otherwise eliminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(h) [Reserved]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(i) In order to assure the
viability of Awards granted to Participants employed in various jurisdictions, the Administrator may, in its sole discretion, provide
for such special terms as it may consider necessary or appropriate to accommodate differences in local law, tax policy, or custom applicable
in the jurisdiction in which the Participant resides or is employed. Moreover, the Administrator may approve such supplements to, amendments,
restatements or alternative versions of this Equity Plan as it may consider necessary or appropriate for such purposes without thereby
affecting the terms of this Equity Plan as in effect for any other purpose; <I>provided, however</I>, that no such supplements, restatements
or alternative versions shall increase the share limitations contained in Section 6 hereof. Notwithstanding the foregoing, the Administrator
may not take any actions hereunder, and no Awards shall be granted, that would violate any Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(j) The Company shall not be
obligated to grant any Awards, permit the exercise of any Awards, issue any Award Shares upon the exercise of any Awards, make any payments
or take any other action pursuant to this Equity Plan if, in the opinion of the Administrator, such action would conflict or be inconsistent
with any Applicable Law or the Company&rsquo;s trading policies, and the Administrator reserves the right to refuse to take such action
for so long as such conflict or inconsistency or issue remains outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(k) The Company shall maintain
a register of Awards granted to the Participants and Award Shares issued to the Participants or an entity designated by the Participants,
including the dates of grant of such Awards and the exercise of such Awards and any other details as the Administrator may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(l) The Equity Plan and all
Award Agreements shall be governed by and construed in accordance with the laws of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 14<I>. Effective Date of Equity Plan.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Equity Plan shall be effective
after the closing the Business Combination, its approval by the Board of the Company and its approval by the shareholders of the Company
(the &ldquo;<B>Effective Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 15<I>. Term of Equity Plan.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No Award shall be granted under
this Equity Plan after the tenth anniversary of the Effective Date. However, unless otherwise expressly provided in this Equity Plan or
in an applicable Award Agreement, any Award theretofore granted may extend beyond such date, and the authority of the Administrator to
amend, alter, adjust, suspend, discontinue, or terminate any such Award, or to waive any conditions or rights under any such Award, and
the authority of the Board to amend this Equity Plan, shall extend beyond such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>ea027116801ex23-2_ydbio.htm
<DESCRIPTION>CONSENT OF CBIZ CPAS P.C
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by reference in
this Registration Statement on Form S-8 of our report dated April 30, 2025 with respect to the financial statements of YD Bio Limited
as of December 31, 2024 and for the period from February 6, 2024 (inception) to December 31, 2024 included in YD Bio Limited&rsquo;s Registration
Statement on Form F-1 (No. 333-290471).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ CBIZ CPAs P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 2, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>5
<FILENAME>ea027116801ex23-3_ydbio.htm
<DESCRIPTION>CONSENT OF MARCUM LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by reference in
this Registration Statement on YD Bio Limited&rsquo;s Form S-8 of our report dated March 11, 2025 with respect to the financial statements
of Breeze Holdings Acquisition Corp. as of, and for each the years ended December 31, 2024 and 2023 included in YD Bio Limited&rsquo;s
Registration Statement on Form F-1 (No. 333-290471).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Marcum LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 2, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>6
<FILENAME>ea027116801ex23-4_ydbio.htm
<DESCRIPTION>CONSENT OF ARK PRO CPA & CO
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><IMG SRC="ex23-4_001.jpg" ALT="" STYLE="height: 60px; width: 650px">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 50%; vertical-align: bottom"></TD><TD STYLE="text-align: right; width: 50%"></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation by reference
in the Registration Statement on Form S-8 of YD Bio Limited of our report dated April 30, 2025, with respect to our audits of the consolidated
financial statements of YD Biopharma Limited and subsidiary (collectively the &ldquo;Company&rdquo;) as of December 31, 2024 and 2023
and for each of the two years in the period ended December 31, 2024 included in YD Bio Limited&rsquo;s Registration Statement on Form
F-1 (No. 333-290471).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ ARK Pro CPA &amp; Co</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ARK Pro CPA &amp; Co</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hong Kong, China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 2, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;<IMG SRC="ex23-4_002.jpg" ALT="" STYLE="height: 51px; width: 650px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>7
<FILENAME>ea027116801ex-fee_ydbio.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FA.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.4a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: b24c999cc783c5a9cc53edc4a79872a0 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-8</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0002011674</ix:nonNumeric>
      <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_004">Fees to be Paid</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0002011674</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-12-29</xbrli:startDate>
          <xbrli:endDate>2025-12-29</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0002011674</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-12-29</xbrli:startDate>
          <xbrli:endDate>2025-12-29</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_007">S-8</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_008">YD Bio Limited</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 16%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 18%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 7%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 10%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 10%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_009">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_010">Ordinary shares, par value $0.0001 per share</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_011">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_012">10,547,974</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">12.03</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">126,892,127.22</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">17,523.80</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 17%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 25%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="12" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" id="fee_017" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">126,892,127.22</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" id="fee_018" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">17,523.80</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="12" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" id="fee_019" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="12" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" id="fee_020" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">17,523.80</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_021">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this registration statement on Form S-8 (the &#8220;Registration Statement&#8221;) to which this exhibit relates shall also cover any additional shares of the ordinary shares of YD Bio Limited (the &#8220;Company,&#8221; and such shares, &#8220;Company Ordinary Shares&#8221;) that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction that results in an increase in the number of outstanding shares of Company Ordinary Shares.<br/><br/>Fee calculated in accordance with Rules 457(c) and 457(h) under the Securities Act.<br/><br/>Represents shares of Company Ordinary Shares reserved for future issuance under the YD Bio Limited Equity Incentive Plan.<br/><br/>Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act and calculated in accordance with Rules 457(c) and 457(h) promulgated thereunder. The aggregate offering price is the average of the high and low prices of shares of Company Ordinary Shares as reported on the Nasdaq Global Market on December 30, 2025.<br/></ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  P '8# 2(  A$! Q$!_\0
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M>ZQXYU/Q&;>YF5K=]-M#:V<%?_@J_P#'KXF?\%/_ /@K?XX\(>"[]/$MK/\
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M&E*K*-3VE[*+LVK.]I76RNE^&URI**:MW5_P/H'_ (*8_P#)=_"?_9)-!_\
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MG6]<\$0ZPU]KFGV^ES/K%W9WOV2SBG2YGBLGM]/LID6^G@M)KI9Y;A3)9P&
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)[]4%%%%2,__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex23-4_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-4_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !1 V\# 2(  A$! Q$!_\0
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MUY<<QA*K[.W6USVIY1.%#VW-K:]K'IM%%%>H>*%%%% "9I<CUKQ34+B<:E=
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M491' 1C^#NYYQCBN T+XC:_H5U).VIP:G;R*9+J'4;V-3YG<0E<[1S]TC'%
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M*V.<\0U'_D)W?_79_P"9K<\(:%9ZW+=+=^9B)5*[&QUS6'J/_(3N_P#KL_\
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MSVRM=V(86TF2/+W#!P!QTH OJ J@   < "EHHH **** "BBB@ HHHH ****
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M:S*1<2DRS9Z[CZUO24W*#;>UW^1S5I4XQFHI;V7?N_NV[:FS1117>>8%%%%
M!1110 445!>7*6=G-<R'"Q(6/X4F[*[&DV[(\X\>:C]JUI;5#E+9<'_>/)_I
M7*U+<W#W5U+<2'+RN7/XUVWP_P!+22*ZOIHE<$^4FX9]R?Y5\JHRQ>(=NOY'
MW#G' 8175[6^\X/(HR*]R^Q6O_/M#_WP*/L5K_S[0_\ ? KN_LE_S_@>9_;J
M_P"??X_\ \.KO?AYJ.4N=.=NG[V,>W0_TK,\=Z:MGK$=Q&@6.X3HHP PX/\
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M?Y5VE<7\1O\ D'67_74_RKNQW^[R/,RW_>X>OZ,\\'WA]17N5NJI;1*H  0
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M X +@C 7GVKI;+Q-J O[31KC2)Y]12U@EOI8601PE\@GD\X(/ H ;]@\=_\
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MGK&G36%_ LUM,,.C?H0>Q'K5NBMCG.>L/!]C8R.TEYJ5ZK0M ([RZ:5%1N"
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MTSP=K2^%[CP]<B&'3;B:-!&9%>2* 8,F655#%B !QQGDUZ-10 B*$15484#
M%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<9XR,(UC26N)I8(0'W2Q?>7ITKLZ:R*WWE!^HK&M3]I#
ME-\/6]C4Y[=_Q1A^&;BQDMIHK*]N;H(P+-<9R,]AGZ5)O@_X2T)]JN//^SY\
MC'[O'K]:V%15^ZH'T%+M&[=@9]:%3:BEV_KN$JJ<Y2MO_7;_ ".;OA_Q7NFG
M'_+I)S^=<T;*!?"CW@@470U'B4#Y@-U>D[06R0,^M)L7&-HQUQBL9X52;;>]
M_P ;?Y'13QC@DDMK?A?_ #.1%FDGC/4BD*F460>-L=)".H]ZQ;-+=X-(M;6V
MD35XKD&=O+(8#)R2?2O2=HSG SZT;1G.!GUI2PB;W[].[3^_0<<<TK6Z+KV3
M7W:['%3&[EU">/RKAPT\OGK;G#%ACRPQZA<<T0K>6NDW%W)92RM'9"&5)U/[
MU]QR2.I !ZUU5SI=I=R^;+%^]QC>C%21Z$CK5F*)(8EBC7"*, 9S36&=VVQ/
M%+E243@_#[J_B9FB,/EM9-GR(3&F<CC!ZD>M:7A73K0>'1=FVC^T_O?WA7YN
MI'6NK"*.B@?A2A0!@  >@HIX51W=]_QL%7&.::2MMU[7_P SS;P]OL9]+O=0
M026<A>* GI ^>I^OK6E:-IUKK5_'K-JSWDEV&A=HB^5_AP?05VWEIMV[5QZ8
MI=H)!P,CI4PPG(DD]NZ\OZMV*J8[G;;C:^FCMUNO^#W/.-3>P74_$274!DN)
M"JVY$9;#8['L>E7=2FDAM]+M+RV@4_8^9[B R'=C[@ [UU5GI,=GJ-]>"0NU
MVRL58#"X&.*T"H/4 _6ICA96=W:_^=RY8V-XI*Z7GULEIV_4Y/PUJ<.G>&]/
M2Z\P&:9HHP%)P=W&?054MVTZTUW44UJV,EU+<AH&:(OE>V#[5VVQ>/E''3BE
M*@D$@9'0UK]7?+%7V\O(P^M+FE*WQ>?G?_A^YYQ?K:QC6[>]M7?4YIB;5O+)
M)'\.TUJ)81W7B:**_A65DTU=P<9^;H:[,J"02!D=Z-HSG SZU*PB3U?X>KU^
M\TECFU9*VG?R2T[;'FD=G!%X2LKQ(0MT+X#S0/FQNQUKL=2U.WN+;5K"/?Y\
M%LQ?*\<CL:V=B8QM&/3%&Q<D[1D]>.M53P_(FHO=6_!_YD5,7[1J4ELV]_-/
M]/Q.!M;."VM_"EQ#"L<\LN)'48+?6J:I-!?W-_/'YVFP:BQEAQW/\>.^*]*V
M+Q\HXZ<=*-BX(VC!Z\=:S>#6EGM_DE^AJLP:;;5[^?FW^MD)$ZRQ+(A!1@"I
M'<4^D  & ,"EKO/,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex23-4_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-4_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z N,# 2(  A$! Q$!_\0
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M&&[IN  SC&.GK6MHUS<RW<JRO-)&L>0S=,YZ8VCFLP:7="U\M8W=S8,I&Q@
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M]U'=);I*4P#OVX8CVS^E6;&:\75KFSNITF2.%)$81[3R6!SCZ4*JFTOZZ_Y
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#C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Dec. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0002011674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">YD Bio Limited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Dec. 29, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Ordinary shares, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">10,547,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">12.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 126,892,127.22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 17,523.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this registration statement on Form S-8 (the &#8220;Registration Statement&#8221;) to which this exhibit relates shall also cover any additional shares of the ordinary shares of YD Bio Limited (the &#8220;Company,&#8221; and such shares, &#8220;Company Ordinary Shares&#8221;) that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction that results in an increase in the number of outstanding shares of Company Ordinary Shares.<br/><br/>Fee calculated in accordance with Rules 457(c) and 457(h) under the Securities Act.<br/><br/>Represents shares of Company Ordinary Shares reserved for future issuance under the YD Bio Limited Equity Incentive Plan.<br/><br/>Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act and calculated in accordance with Rules 457(c) and 457(h) promulgated thereunder. The aggregate offering price is the average of the high and low prices of shares of Company Ordinary Shares as reported on the Nasdaq Global Market on December 30, 2025.<br/><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Dec. 29, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 126,892,127.22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">17,523.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 17,523.80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>21</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea027116801ex-fee_ydbio.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea027116801ex-fee_ydbio.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea027116801ex-fee_ydbio.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea027116801ex-fee_ydbio.htm">ea027116801ex-fee_ydbio.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea027116801ex-fee_ydbio.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea027116801ex-fee_ydbio.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 21,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 19,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea027116801ex-fee_ydbio.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea027116801ex-fee_ydbio.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea027116801ex-fee_ydbio.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea027116801ex-fee_ydbio.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea027116801ex-fee_ydbio.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea027116801ex-fee_ydbio.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001213900-26-000315-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-000315-xbrl.zip
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M/D0B#  5?+\ Y@9AP_'27F<_<<BYL$,EO4ZGTU&-?L%"N0_('1"AZ1U2DBP
M'&^O()Z0"0IQ0WLLX:D/N2U$;;G#"##4_GH[4#0%[L[ @QNY68L*D_Y-+BVW
M \'XF?K/+$P$Y\R(WEKFU0P)'Z-&BE_4^XUV87R;E>S#L"7C.W+<FO&)>>W?
M4$L! A0#%     @ TVDB7 0DQBDT"P  :#,  !L              ( !
M &5A,#(W,3$V.# Q97@M9F5E7WED8FEO+FAT;5!+!08      0 ! $D   !M
%"P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>ea027116801ex-fee_ydbio_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002011674</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-29</startDate>
            <endDate>2025-12-29</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002011674</identifier>
        </entity>
        <period>
            <startDate>2025-12-29</startDate>
            <endDate>2025-12-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-8</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0002011674</dei:EntityCentralIndexKey>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_004">false</ffd:PrevslyPdFlg>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_007">S-8</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_008">YD Bio Limited</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_009">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_010">Ordinary shares, par value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_1" id="fee_011">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_012"
      unitRef="shares">10547974</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_013"
      unitRef="USD">12.03</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">126892127.22</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">17523.80</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_017"
      unitRef="USD">126892127.22</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_018"
      unitRef="USD">17523.80</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_019"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_020"
      unitRef="USD">17523.80</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_021">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement on Form S-8 (the &#x201c;Registration Statement&#x201d;) to which this exhibit relates shall also cover any additional shares of the ordinary shares of YD Bio Limited (the &#x201c;Company,&#x201d; and such shares, &#x201c;Company Ordinary Shares&#x201d;) that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction that results in an increase in the number of outstanding shares of Company Ordinary Shares.&lt;br/&gt;&lt;br/&gt;Fee calculated in accordance with Rules 457(c) and 457(h) under the Securities Act.&lt;br/&gt;&lt;br/&gt;Represents shares of Company Ordinary Shares reserved for future issuance under the YD Bio Limited Equity Incentive Plan.&lt;br/&gt;&lt;br/&gt;Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act and calculated in accordance with Rules 457(c) and 457(h) promulgated thereunder. The aggregate offering price is the average of the high and low prices of shares of Company Ordinary Shares as reported on the Nasdaq Global Market on December 30, 2025.&lt;br/&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
